Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Experientia|October 15, 1979
TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidismG Schernthaner, H Ludwig, H Schleusener, et al.Journal of Endocrinological Investigation|June 1, 1984
10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb)J Hensen, P Kotulla, R Finke, et al.Acta Endocrinologica|September 1, 1990
Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspringP M Messer, B P Hauffa, T Olbricht, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1984
Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: correlation with thyrotropin binding-inhibiting antibodiesJ Hensen, P Kotulla, R Finke, et al.Experimental and Clinical Endocrinology|May 1, 1991
The relevance of genetic susceptibility in Graves' disease and immune thyroiditisH Schleusener, U Bogner, H Peters, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1978
Relationship between thyroid status and Graves' disease-specific immunoglobulinsH Schleusener, P Kotulla, R Finke, et al.Acta Endocrinologica. Supplementum|January 1, 1987
Do HLA-DR-typing and measurement of TSH-receptor antibodies help in the prediction of the clinical course of Graves' thyrotoxicosis after antithyroid drug treatment?H Schleusener, J Schwander, G Holl, et al.The Journal of Clinical Endocrinology and Metabolism|April 1, 1983
HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiterH Schleusener, G Schernthaner, W R Mayr, et al.Pageof 2